Kevin Koch's Net Worth

$1.22 Million

Estimate Recalculated Nov 1, 2024 02:23PM EST

Who is Kevin Koch

Kevin Koch has an estimated net worth of $1.22 Million. This is based on reported shares across multiple companies, which include MIRAGEN THERAPEUTICS, INC., Edgewise Therapeutics, Inc., and ARRAY BIOPHARMA INC.

SEC CIK

Kevin Koch's CIK is 0001185829

Past Insider Trading and Trends

2005 was Kevin Koch's most active year for acquiring shares with 3 total transactions. Kevin Koch's most active month to acquire stocks was the month of July. 2013 was Kevin Koch's most active year for disposing of shares, totalling 3 transactions. Kevin Koch's most active month to dispose stocks was the month of April. 2013 saw Kevin Koch paying a total of $83,572.50 for 142,286 shares, this is the most they've acquired in one year. In 2007 Kevin Koch cashed out on 46,900 shares for a total of $657,700.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MIRAGEN THERAPEUTICS, INC.

Investor
Updated May 22, 2020
Form 4
24.00K
May 22, 2020
24.00K
Grant
May 21
Form 4
12.00K
Jun 21, 2019
12.00K
Grant
Jun 19
Form 4
12.00K
Jun 28, 2018
12.00K
Grant
Jun 27
Form 4
12.00K
Jun 30, 2017
12.00K
Grant
Jun 28
Form 3
Feb 13, 2017
Showing 5 results

Edgewise Therapeutics, Inc.

President and CEO
Updated Aug 14, 2024
Form 4
503.13K
Aug 14, 2024
503.13K
Grant
Aug 12
Form 4
-11.24%
-3.15K
$18.91
-$59.60K
May 03, 2024
363.68K
Sale
May 01 - May 02
Form 4
600.00K
Aug 18, 2023
600.00K
Grant
Aug 17
Form 4
-10.25%
-3.20K
$8.90
-$28.52K
May 03, 2023
366.83K
Sale
May 01 - May 02
Form 4
550.00K
Aug 10, 2022
550.00K
Grant
Aug 08
Form 4
31.25K
May 03, 2022
31.25K
Grant
May 01
Form 4
400.00K
Aug 19, 2021
400.00K
Grant
Aug 17
Form 3
Mar 25, 2021
338.78K
Showing 8 results

ARRAY BIOPHARMA INC

President, CSO
Updated Aug 02, 2013
Form 4/A
-1.29%
-10.32K
$6.07
-$62.66K
Aug 02, 2013
929.20K
Tax
Jul 24
Form 4
-1.55%
-12.37K
$4.91
$8.52K
Jul 25, 2013
927.16K
Options
Jul 24
Form 4
120.00K
Apr 01, 2013
120.00K
Grant
Mar 28
Form 4
3.02%
22.72K
Oct 05, 2012
917.24K
Grant
Oct 04
Form 4
90.00K
Apr 03, 2012
90.00K
Grant
Mar 30
Form 4
7.16%
50.27K
Oct 04, 2011
894.52K
Grant
Oct 04
Form 4
75.00K
Apr 05, 2011
75.00K
Grant
Mar 31
Form 4
7.35%
48.03K
Oct 06, 2010
844.25K
Grant
Oct 04
Form 4
75.00K
Apr 01, 2010
75.00K
Grant
Mar 31
Form 4
$0.60
$17.32K
Nov 13, 2009
796.22K
Options
Nov 12
Form 4
5.86%
34.60K
Oct 06, 2009
767.36K
Grant
Oct 05
Form 4
75.00K
May 01, 2009
75.00K
Grant
Apr 29
Form 4
75.00K
Sep 11, 2008
75.00K
Grant
Sep 09
Form 4
$0.24
$8.25K
Feb 14, 2008
732.76K
Options
Feb 12
Form 4
-3.48%
-20.00K
$14.06
-$281.10K
Feb 07, 2007
697.64K
Sale
ScheduledFeb 05
Form 4
-4.47%
-26.90K
$14.00
-$376.60K
Jan 19, 2007
717.64K
Sale
Jan 19
Form 4
-3.21%
-20.00K
$9.38
-$187.68K
Feb 22, 2006
744.54K
Sale
ScheduledFeb 17
Form 4
$3.75
$2.99K
Oct 03, 2005
764.54K
Options
Sep 27
Form 4
300.00K
Aug 08, 2005
300.00K
Grant
Aug 04
Form 4
$0.37
$3.37K
Jun 27, 2005
763.74K
Options
Jun 24
Form 4
12.30K
Aug 03, 2004
12.30K
Grant
Jul 30
Form 4
44.24K
Aug 04, 2003
44.25K
Grant
Jul 01 - Aug 01
Form 4/A
May 14, 2003
Form 4
May 09, 2003
Showing 24 results